Literature DB >> 27481956

Stimulatory Effects of Mesenchymal Stem Cells on cKit+ Cardiac Stem Cells Are Mediated by SDF1/CXCR4 and SCF/cKit Signaling Pathways.

Konstantinos E Hatzistergos1, Dieter Saur1, Barbara Seidler1, Wayne Balkan1, Matthew Breton1, Krystalenia Valasaki1, Lauro M Takeuchi1, Ana Marie Landin1, Aisha Khan1, Joshua M Hare2.   

Abstract

RATIONALE: Culture-expanded cells originating from cardiac tissue that express the cell surface receptor cKit are undergoing clinical testing as a cell source for heart failure and congenital heart disease. Although accumulating data support that mesenchymal stem cells (MSCs) enhance the efficacy of cardiac cKit(+) cells (CSCs), the underlying mechanism for this synergistic effect remains incompletely understood.
OBJECTIVE: To test the hypothesis that MSCs stimulate endogenous CSCs to proliferate, migrate, and differentiate via the SDF1/CXCR4 and stem cell factor/cKit pathways. METHODS AND
RESULTS: Using genetic lineage-tracing approaches, we show that in the postnatal murine heart, cKit(+) cells proliferate, migrate, and form cardiomyocytes, but not endothelial cells. CSCs exhibit marked chemotactic and proliferative responses when cocultured with MSCs but not with cardiac stromal cells. Antagonism of the CXCR4 pathway with AMD3100 (an SDF1/CXCR4 antagonist) inhibited MSC-induced CSC chemotaxis but stimulated CSC cardiomyogenesis (P<0.0001). Furthermore, MSCs enhanced CSC proliferation via the stem cell factor/cKit and SDF1/CXCR4 pathways (P<0.0001).
CONCLUSIONS: Together these findings show that MSCs exhibit profound, yet differential, effects on CSC migration, proliferation, and differentiation and suggest a mechanism underlying the improved cardiac regeneration associated with combination therapy using CSCs and MSCs. These findings have important therapeutic implications for cell-based therapy strategies that use mixtures of CSCs and MSCs.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  coculture techniques; mesenchymal stromal cells; myocytes, cardiac; receptors, CXCR4; stem cell factor

Mesh:

Substances:

Year:  2016        PMID: 27481956      PMCID: PMC5180614          DOI: 10.1161/CIRCRESAHA.116.309281

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  46 in total

1.  CreER(T2) expression from within the c-Kit gene locus allows efficient inducible gene targeting in and ablation of mast cells.

Authors:  Klaus Heger; Barbara Seidler; J Christoph Vahl; Christian Schwartz; Maike Kober; Sabine Klein; David Voehringer; Dieter Saur; Marc Schmidt-Supprian
Journal:  Eur J Immunol       Date:  2013-10-14       Impact factor: 5.532

2.  Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation.

Authors:  Konstantinos E Hatzistergos; Henry Quevedo; Behzad N Oskouei; Qinghua Hu; Gary S Feigenbaum; Irene S Margitich; Ramesh Mazhari; Andrew J Boyle; Juan P Zambrano; Jose E Rodriguez; Raul Dulce; Pradip M Pattany; David Valdes; Concepcion Revilla; Alan W Heldman; Ian McNiece; Joshua M Hare
Journal:  Circ Res       Date:  2010-07-29       Impact factor: 17.367

Review 3.  Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.

Authors:  Sudhir H Ranganath; Oren Levy; Maneesha S Inamdar; Jeffrey M Karp
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

4.  Stem cell factor gene transfer improves cardiac function after myocardial infarction in swine.

Authors:  Kiyotake Ishikawa; Kenneth Fish; Jaume Aguero; Elisa Yaniz-Galende; Dongtak Jeong; Changwon Kho; Lisa Tilemann; Lauren Fish; Lifan Liang; Ahmed A Eltoukhy; Daniel G Anderson; Krisztina Zsebo; Kevin D Costa; Roger J Hajjar
Journal:  Circ Heart Fail       Date:  2014-10-23       Impact factor: 8.790

5.  The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction.

Authors:  Polina Goichberg; Yingnan Bai; Domenico D'Amario; João Ferreira-Martins; Claudia Fiorini; Hanqiao Zheng; Sergio Signore; Federica del Monte; Sergio Ottolenghi; David A D'Alessandro; Robert E Michler; Toru Hosoda; Piero Anversa; Jan Kajstura; Marcello Rota; Annarosa Leri
Journal:  Circ Res       Date:  2011-03-17       Impact factor: 17.367

6.  Existing cardiomyocytes generate cardiomyocytes at a low rate after birth in mice.

Authors:  Shah R Ali; Simon Hippenmeyer; Lily V Saadat; Liqun Luo; Irving L Weissman; Reza Ardehali
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-29       Impact factor: 11.205

7.  Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart.

Authors:  Ge Zhang; Yasushiro Nakamura; Xiaohong Wang; Qingsong Hu; Laura J Suggs; Jianyi Zhang
Journal:  Tissue Eng       Date:  2007-08

8.  Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair.

Authors:  Elisa Avolio; Marco Meloni; Helen L Spencer; Federica Riu; Rajesh Katare; Giuseppe Mangialardi; Atsuhiko Oikawa; Iker Rodriguez-Arabaolaza; Zexu Dang; Kathryn Mitchell; Carlotta Reni; Valeria V Alvino; Jonathan Rowlinson; Ugolini Livi; Daniela Cesselli; Gianni Angelini; Costanza Emanueli; Antonio P Beltrami; Paolo Madeddu
Journal:  Circ Res       Date:  2015-03-23       Impact factor: 17.367

9.  SCF/c-kit transactivates CXCR4-serine 339 phosphorylation through G protein-coupled receptor kinase 6 and regulates cardiac stem cell migration.

Authors:  Ke Zuo; Dong Kuang; Ying Wang; Yanli Xia; Weilin Tong; Xiaoyan Wang; Yaobin Chen; Yaqi Duan; Guoping Wang
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

10.  Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair.

Authors:  Zhiwei Zhang; Junjie Yang; Weiya Yan; Yangxin Li; Zhenya Shen; Takayuki Asahara
Journal:  J Am Heart Assoc       Date:  2016-01-25       Impact factor: 5.501

View more
  39 in total

Review 1.  microRNAs and cardiac stem cells in heart development and disease.

Authors:  Bo Li; Xianmei Meng; Lubo Zhang
Journal:  Drug Discov Today       Date:  2018-05-28       Impact factor: 7.851

2.  The promise of stromal cell-derived factor-1 in novel heart disease treatments.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2017-08       Impact factor: 4.599

Review 3.  Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges.

Authors:  Luiza Bagno; Konstantinos E Hatzistergos; Wayne Balkan; Joshua M Hare
Journal:  Mol Ther       Date:  2018-05-25       Impact factor: 11.454

Review 4.  The Biological Mechanisms of Action of Cardiac Progenitor Cell Therapy.

Authors:  Francesca Pagano; Vittorio Picchio; Francesco Angelini; Alessandra Iaccarino; Mariangela Peruzzi; Elena Cavarretta; Giuseppe Biondi-Zoccai; Sebastiano Sciarretta; Elena De Falco; Isotta Chimenti; Giacomo Frati
Journal:  Curr Cardiol Rep       Date:  2018-08-13       Impact factor: 2.931

5.  A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration.

Authors:  Makoto Natsumeda; Victoria Florea; Angela C Rieger; Bryon A Tompkins; Monisha N Banerjee; Samuel Golpanian; Julia Fritsch; Ana Marie Landin; Nilesh D Kashikar; Vasileios Karantalis; Viky Y Loescher; Kostas E Hatzistergos; Luiza Bagno; Cristina Sanina; Muzammil Mushtaq; Jose Rodriguez; Marcos Rosado; Ariel Wolf; Kevin Collon; Louis Vincent; Anthony J Kanelidis; Ivonne H Schulman; Raul Mitrani; Alan W Heldman; Wayne Balkan; Joshua M Hare
Journal:  J Am Coll Cardiol       Date:  2017-11-14       Impact factor: 24.094

6.  Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.

Authors:  Joshua M Hare; Darcy L DiFede; Angela C Rieger; Victoria Florea; Ana M Landin; Jill El-Khorazaty; Aisha Khan; Muzammil Mushtaq; Maureen H Lowery; John J Byrnes; Robert C Hendel; Mauricio G Cohen; Carlos E Alfonso; Krystalenia Valasaki; Marietsy V Pujol; Samuel Golpanian; Eduard Ghersin; Joel E Fishman; Pradip Pattany; Samirah A Gomes; Cindy Delgado; Roberto Miki; Fouad Abuzeid; Mayra Vidro-Casiano; Courtney Premer; Audrey Medina; Valeria Porras; Konstantinos E Hatzistergos; Erica Anderson; Adam Mendizabal; Raul Mitrani; Alan W Heldman
Journal:  J Am Coll Cardiol       Date:  2016-11-14       Impact factor: 24.094

7.  Enhancing the precision of genetic lineage tracing using dual recombinases.

Authors:  Lingjuan He; Yan Li; Yi Li; Wenjuan Pu; Xiuzhen Huang; Xueying Tian; Yue Wang; Hui Zhang; Qiaozhen Liu; Libo Zhang; Huan Zhao; Juan Tang; Hongbin Ji; Dongqing Cai; Zhibo Han; Zhongchao Han; Yu Nie; Shengshou Hu; Qing-Dong Wang; Ruilin Sun; Jian Fei; Fengchao Wang; Ting Chen; Yan Yan; Hefeng Huang; William T Pu; Bin Zhou
Journal:  Nat Med       Date:  2017-11-13       Impact factor: 53.440

Review 8.  The Elusive Progenitor Cell in Cardiac Regeneration: Slip Slidin' Away.

Authors:  Chen-Leng Cai; Jeffery D Molkentin
Journal:  Circ Res       Date:  2017-01-20       Impact factor: 17.367

9.  A Deep Proteome Analysis Identifies the Complete Secretome as the Functional Unit of Human Cardiac Progenitor Cells.

Authors:  Sudhish Sharma; Rachana Mishra; Grace E Bigham; Brody Wehman; Mohd M Khan; Huichun Xu; Progyaparamita Saha; Young Ah Goo; Srinivasa Raju Datla; Ling Chen; Mohan E Tulapurkar; Bradley S Taylor; Peixin Yang; Sotirios Karathanasis; David R Goodlett; Sunjay Kaushal
Journal:  Circ Res       Date:  2016-12-01       Impact factor: 17.367

10.  Physiological and hypoxic oxygen concentration differentially regulates human c-Kit+ cardiac stem cell proliferation and migration.

Authors:  Michael A Bellio; Claudia O Rodrigues; Ana Marie Landin; Konstantinos E Hatzistergos; Jeffim Kuznetsov; Victoria Florea; Krystalenia Valasaki; Aisha Khan; Joshua M Hare; Ivonne Hernandez Schulman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-30       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.